Interestingly, prior vaccination against human papillomaviruses in patients with cervical cancer led to an increase of CD103+CD8+ TIL by 25% and, consequently, to a better prognosis in terms of survival and response to therapy [84]. This evidence concerns the gene ITGAE and cervical carcinoma.